Home › Encyclopedia › Anamorelin: Research Status and Clinical Trial Data
Research / Unapproved

Anamorelin: Research Status and Clinical Trial Data

Molecular formulaC31H42N6O3
Molecular weight546.7 g/mol
Registered trials11
PubChem CID9828911

What Anamorelin Is

Anamorelin is a synthetic compound (PubChem CID 9828911) that has not received approval from a drug regulatory authority. No approved product label exists for this compound, so no authorized indications, dosing, or safety labeling apply. It remains classified as an investigational research compound.

Trial Footprint

Eleven clinical trials involving anamorelin have been registered. Research has focused on conditions involving appetite and weight loss related to cancer. One phase 2 study examined the role of ghrelin biology in cancer cachexia but was terminated. A completed phase 2 study assessed a dose range of anamorelin in patients with non-small cell lung cancer. A more recent phase 2/3 study has evaluated anamorelin hydrochloride for reducing anorexia in patients with advanced non-small cell lung cancer and was listed as active but not recruiting.

FAQ

Is anamorelin FDA-approved?
No. Anamorelin has not received approval from a drug regulatory authority and no approved product label exists for it. It remains an investigational compound studied in clinical research settings.
What conditions has anamorelin been studied for?
Registered trials have examined anamorelin in the context of cancer-related cachexia and anorexia, particularly in patients with non-small cell lung cancer. These studies include terminated, completed, and ongoing trials at various phases.
How many clinical trials have studied anamorelin?
Eleven clinical trials involving anamorelin have been registered. These include studies ranging from early dose-finding work to later-stage trials evaluating its effects on anorexia in lung cancer patients.
Is there safety data available for anamorelin?
Because no approved drug label or adverse event reporting data is available for anamorelin in this dataset, no summary of reported side effects can be provided. Safety information from individual clinical trials may exist separately.
What is the chemical identity of anamorelin?
Anamorelin has the molecular formula C31H42N6O3 and a molecular weight of approximately 546.7. It is cataloged under PubChem CID 9828911.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem ClinicalTrials.gov

Updated 2026-09-19